Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
27.53
+0.44 (1.62%)
Dec 20, 2024, 4:00 PM EST - Market closed
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $771.04 million as of December 20, 2024. Its market cap has increased by 48.46% in one year.
Market Cap
771.04M
Enterprise Value
518.00M
1-Year Change
48.46%
Ranking
Category
Stock Price
$27.53
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $771.04M, an increase of 526.60%. That is a compound annual growth rate of 40.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 771.04M | 32.77% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | 1.62B | 176.41% |
| Dec 31, 2019 | 586.84M | 376.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 800.44M |
| Cytek Biosciences | 797.34M |
| Avid Bioservices | 788.67M |
| agilon health | 774.59M |
| Tyra Biosciences | 766.64M |
| uniQure | 754.06M |
| Standard BioTools | 738.93M |
| Cronos Group | 725.92M |